Navigation Links
LawInfo Provides Access to Qualified Hydroxycut Litigation Attorneys Nationwide
Date:5/26/2009

Due to the recent recall of 14 Hydroxycut products, consumers who have suffered injuries from using Hydroxycut are encouraged to seek the legal counsel of an experienced products liability attorney to determine if he/she is eligible for compensation. Lawinfo provides access to pre-screened and pre-qualified Hydroxycut trial attorneys nationwide.

San Diego, CA (PRWEB) May 26, 2009 -- For over 15 years, LawInfo has been the premier legal information website. LawInfo's primary goal is to provide consumers with access to qualified legal professionals, while creating attorney business solutions for clients nationwide.

On May 1, 2009, the FDA announced a recall of 14 different Hydroxycut weight-loss products by the drug's manufacturer, Iovate Health Sciences, following at least 23 reports of associated liver damage. Although dietary supplements such as Hydroxycut do not require FDA approval before they are marketed, and are not closely monitored like prescription medications, all drug manufacturers have a legal responsibility to inform physicians and consumers regarding any possible risks associated with their drug(s). If they fail to do so, they can be held liable to injured consumers under a legal theory known as "products liability." Such liability can include providing financial compensation for medical treatment, loss of work, loss of income, etc.

In addition to hosting thousands of free pages of legal information covering every aspect of the law, and online videos providing answers to commonly asked legal questions, LawInfo also provides an

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Study provides hope that some transplant patients could live free of antirejection drugs
2. Study provides hope that some transplant patients could live free of anti-rejection drugs
3. USAID Provides Additional Wildfire Assistance to Greece
4. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
5. New knock-out gene model provides molecular clues to breast cancer
6. PreMD Provides Update on 510(k) Application for PREVU(x) POC
7. SIV infection of natural hosts provides new insights into HIV disease complexity
8. Microarray provides 3 genomic guides to breast cancer treatment decisions
9. Access Innovations Provides Support Services for Agis Network
10. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
11. Physical Therapist Provides Injury Analysis for Fantasy Football
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:NABP Expanding Computer-Based Test Delivery to Include Foreign Pharmacy Graduate Equivalency Examination(R) 2Health News:MiddleBrook Pharmaceuticals to Launch Moxatag(TM) March 2009 2Health News:MiddleBrook Pharmaceuticals to Launch Moxatag(TM) March 2009 3Health News:MiddleBrook Pharmaceuticals to Launch Moxatag(TM) March 2009 4Health News:Stem Cell Product Commercialization Focus of Summit 2Health News:Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company License to Certain Alzheimer's Patents and Patent Applications 2Health News:Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company License to Certain Alzheimer's Patents and Patent Applications 3Health News:Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company License to Certain Alzheimer's Patents and Patent Applications 4Health News:Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company License to Certain Alzheimer's Patents and Patent Applications 5Health News:Crucial OTC Marketing Issues to be Addressed by New OTC Perspectives Division of DTC Perspectives, Inc. 2Health News:National Association of Therapeutic Schools and Programs Announces New Executive Director 2
Breaking Medicine Technology:Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Daniel K. Spiegelman Elected to Board of Directors of Omeros 2Shanghai ChemPartner Is Pleased to be Part of Agios' Groundbreaking Cancer Research 2Hydroxycut 28R 29 Litigation Focus of July 28 Conference in San Francisco 48781 1Hydroxycut 28R 29 Litigation Focus of July 28 Conference in San Francisco 48781 2Hydroxycut 28R 29 Litigation Focus of July 28 Conference in San Francisco 48781 3Hydroxycut 28R 29 Litigation Focus of July 28 Conference in San Francisco 48781 4New Treatment Option at The Sarah Cannon Cancer Center Provides Hope for Inoperable Tumors 48776 1New Treatment Option at The Sarah Cannon Cancer Center Provides Hope for Inoperable Tumors 48776 2New Treatment Option at The Sarah Cannon Cancer Center Provides Hope for Inoperable Tumors 48776 3Western Governors University Offers Special Nursing Scholarships for Employees of Hospital Partners 48772 1Western Governors University Offers Special Nursing Scholarships for Employees of Hospital Partners 48772 2Western Governors University Offers Special Nursing Scholarships for Employees of Hospital Partners 48772 3